Report overview
Medications are used to try to help reduce symptoms of gastroparesis. The drug categories commonly used are prokinetic (promotility) agents and antiemetic agents.
This report aims to provide a comprehensive presentation of the global market for Gastroparesis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gastroparesis Drugs. This report contains market size and forecasts of Gastroparesis Drugs in global, including the following market information:
Global Gastroparesis Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gastroparesis Drugs Market Sales, 2018-2023, 2024-2029, (Kg)
Global top five Gastroparesis Drugs companies in 2022 (%)
The global Gastroparesis Drugs market was valued at US$ 5822.8 million in 2022 and is projected to reach US$ 7722 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is the largest consumer of Gastroparesis Drugs in global market.The second place is Europe, following North America.
Market is not concentrated. Sumitomo, Cadila Pharmaceuticals, Sanofi, Teva and Johnson & Johnsonare the leaders of the industry, and hold the key technologies and patent, with high-end customers.
We surveyed the Gastroparesis Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastroparesis Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, by Type, 2022 (%)
Prokinetic Agents
Antiemetic Agents
Others
Global Gastroparesis Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, by Application, 2022 (%)
Diabetic Gastroparesis
Idiopathic Gastroparesis
Global Gastroparesis Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Kg)
Global Gastroparesis Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gastroparesis Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gastroparesis Drugs revenues share in global market, 2022 (%)
Key companies Gastroparesis Drugs sales in global market, 2018-2023 (Estimated), (Kg)
Key companies Gastroparesis Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Cadila Pharmaceuticals
Sanofi
Teva
Johnson & Johnson
Pfizer
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Ani Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gastroparesis Drugs, market overview.
Chapter 2: Global Gastroparesis Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gastroparesis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gastroparesis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gastroparesis Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
